PAK4 inhibitors (Arcus Biosciences)

N/A

Report date: 2025/03/19 11:39:50
NME

Base Information

Drug NamePAK4 inhibitors (Arcus Biosciences)
Drug Alias Namep21-activated kinase 4 inhibitors (Arcus Biosciences)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase PAK 4 inhibitors
TargetsSerine/threonine-protein kinase PAK 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArcus Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesArcus Biosciences Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A